Drug Design for AMP-Activated Protein Kinase Agonists in Silico

AMP-activated protein kinase (AMPK) is a metabolitesensed protein kinase in various eukaryotes. The activated AMPK regulates important proteins which cause diabetes, obesity, metabolic aberrant, and also breast cancer. In this study, the yeast AMPK structure was used as a template to model the human AMPK structure. By homology modeling, the reliable AMPK structure was built, and the active binding site was defined corresponding to X-ray crystal structure of yeast AMPK By virtual screening the database. All the potent ligands had the H-bond interaction in the key residues, same as the control. Thus, we suggested the phenylamide derivates might be the potent AMPK agonists. KeywordsAMPK; AMP; AICAR

[1]  D. Hardie,et al.  Management of cellular energy by the AMP‐activated protein kinase system , 2003, FEBS letters.

[2]  B. Kemp,et al.  Dealing with energy demand: the AMP-activated protein kinase. , 1999, Trends in biochemical sciences.

[3]  M. Davidson,et al.  An overview of metformin in the treatment of type 2 diabetes mellitus. , 1997, The American journal of medicine.

[4]  Kevin P. Claffey,et al.  Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERα negative MDA-MB-435 breast cancer model , 2008, Breast Cancer Research and Treatment.

[5]  H. Koh,et al.  AMPK links energy status to cell structure and mitosis. , 2007, Biochemical and biophysical research communications.

[6]  Nahum Sonenberg,et al.  Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells. , 2006, Cancer research.

[7]  Alastair M. Thompson,et al.  Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERα negative MDA-MB-435 breast cancer model , 2009, Breast Cancer Research and Treatment.

[8]  Kei Sakamoto,et al.  LKB1-dependent signaling pathways. , 2006, Annual review of biochemistry.

[9]  S. Hawley,et al.  5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? , 1995, European journal of biochemistry.

[10]  C. Semenkovich,et al.  Regulation of fatty acid synthase (FAS). , 1997, Progress in lipid research.

[11]  Bruce E. Kemp,et al.  Regulation of 5′-AMP-activated Protein Kinase Activity by the Noncatalytic β and γ Subunits* , 1996, The Journal of Biological Chemistry.

[12]  Samy I McFarlane,et al.  Metformin: An Update , 2002, Annals of Internal Medicine.

[13]  David Carling,et al.  A common bicyclic protein kinase cascade inactivates the regulatory enzymes of fatty acid and cholesterol biosynthesis , 1987, FEBS letters.

[14]  M. Carlson,et al.  The Snf1 protein kinase and its activating subunit, Snf4, interact with distinct domains of the Sip1/Sip2/Gal83 component in the kinase complex , 1997, Molecular and cellular biology.

[15]  J Widmer,et al.  Regulation of 5'-AMP-activated protein kinase activity by the noncatalytic beta and gamma subunits. , 1996, The Journal of biological chemistry.

[16]  A. Hezel,et al.  LKB1; linking cell structure and tumor suppression , 2008, Oncogene.

[17]  T. Haystead,et al.  Purification of the AMP-activated protein kinase on ATP-gamma-sepharose and analysis of its subunit structure. , 1994, European journal of biochemistry.

[18]  D. Hardie,et al.  AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. , 2005, Cell metabolism.

[19]  David Carling,et al.  Activation of GLUT1 by metabolic and osmotic stress: potential involvement of AMP-activated protein kinase (AMPK). , 2002, Journal of cell science.

[20]  Andrzej Witkowski,et al.  Coupling of the de Novo Fatty Acid Biosynthesis and Lipoylation Pathways in Mammalian Mitochondria* , 2007, Journal of Biological Chemistry.